SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-18-003323
Filing Date
2018-01-23
Accepted
2018-01-23 17:01:53
Documents
2
Group Members
CELGENE ALPINE INVESTMENT CO., LLCCELGENE CORPCELGENE SWITZERLAND LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13D tv483803_sc13da.htm SC 13D/A 106714
2 EXHIBIT 7 tv483803_ex99-7.htm EX-99.7 17414
  Complete submission text file 0001144204-18-003323.txt   125673
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS INC (Subject) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87570 | Film No.: 18543012
SIC: 2834 Pharmaceutical Preparations

Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 908-673-9000
Celgene European Investment Co LLC (Filed by) CIK: 0001577650 (see all company filings)

IRS No.: 900587060 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A